Description: Changes in gut and oral bacteria are linked to worsening cognitive symptoms in people with Parkinson's disease.

Parkinson’s is a brain disorder primarily associated with movement problems like shaking, stiffness and difficulty with ...

Bacteria in the mouth and gut may play a significant role in the progression of cognitive decline in Parkinson’s disease, ...

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that ...

It was 2006 when Dr. Daniel Gibbs first noticed he was losing his sense of smell. But it wasn't what he didn't smell that tipped him off that something might be wrong.

Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions such as MS.

Gov. Mike Braun backed an 11th-hour provision in the budget bill ending three alumni-selected members of the Indiana University Board of Trustees, though no one from IU President Pamela Whitten’s ...

A GRANDMOTHER says that East Lothian Council has robbed her husband of spending his final years in their dream home.